The Financial Impact of Introducing Darbepoetin Alfa (DA) as a New Long-Acting Erythropoiesis-Stimulating Agent Alternative for Non-Adherent Peritoneal Dialysis Patients in the Ministry of Health (MOH) Malaysia
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.862
https://www.valueinhealthjournal.com/article/S1098-3015(18)33219-4/fulltext
Title :
The Financial Impact of Introducing Darbepoetin Alfa (DA) as a New Long-Acting Erythropoiesis-Stimulating Agent Alternative for Non-Adherent Peritoneal Dialysis Patients in the Ministry of Health (MOH) Malaysia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33219-4&doi=10.1016/j.jval.2018.07.862
First page :
Section Title :
Open access? :
No
Section Order :
92